Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon on Thursday said its board has approved to acquire 1.5% equity share capital for Rs 550 crore in Biocon Biologics, from one of its existing investors who decided to exercise the liquidity option, in an all cash deal. Post this purchase, Biocon’s stake in Biocon Biologics will be 90.2%. The purchase is expected to … Read more